Results
1 -
10 of
15Novel oral chemotherapy agents, Current Oncology Reports The Tegafur-Based Dihydropyrimidine Dehydrogenase Inhibitory Fluoropyrimidines, UFT/Leucovorin (ORZEL and S-1: a Review of Their Clinical Development and Therapeutic Potential, Investigational New Drugs Polyethylenimine-cyclodextrin-tegafur conjugate shows anti-cancer activity and a potential for gene delivery, Journal of Zhejiang University SCIENCE B Germline Polymorphisms may Act as Predictors of Response to Preoperative Chemoradiation in Locally Advanced T3 Rectal Tumors, Diseases of the Colon & Rectum